United States · Funded startup

Who invested in Montara Therapeutics

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$4.3Mraised across 2 rounds since 2025, from 2 sources

$3.3MGrant$1.0MGrant
Latest round
Grant, $1.0MJun 2026
Biggest round
$3.3MGrant · May 2025
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026
$3.3MGrant$1.0MGrant
First round
Grant, $3.3M
May 2025
Biggest round
$3.3M
Grant · May 2025
Between rounds
13 months
from the last two

The rounds

  1. Jun 2026
    Grant$1.0M1 returning

    Source recorded

  2. May 2025
    Grant$3.3M1 new

    Source recordedSEC filing: $20M sold, first sale Feb 2025

Everyone who backed them

KdT VenturesVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Montara Therapeutics

Who invested in Montara Therapeutics?

Montara Therapeutics's investors include KdT Ventures.

How much has Montara Therapeutics raised?

Montara Therapeutics has raised $4.3M across 2 rounds since 2025.

When did Montara Therapeutics last raise?

Montara Therapeutics's most recent round was a Grant of $1.0M in Jun 2026.

What was Montara Therapeutics's biggest round?

Montara Therapeutics's largest round on record is $3.3M (Grant), in May 2025.

Who backed Montara Therapeutics first?

Montara Therapeutics's first round on record, in May 2025, was backed by KdT Ventures.

What stage is Montara Therapeutics at?

Montara Therapeutics's latest named round is a Grant, in Jun 2026.

Where is Montara Therapeutics based?

Montara Therapeutics is based in the United States.

Companies like Montara Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.